As the biotech sector heats up more in 2017, small
Post# of 2218
Sentiment on the biotech sector early in 2017 sure has improved. The main biotech indices gained approximately 10% in the month of February. The sector has added somewhat to those gains so far in March but continues to be unable to break through stubborn upward resistance levels.
Hopefully, a few more M&A transactions over the next few weeks puts the sector over the top and we can start the next leg of the rally which could take us up another 10% to 15% until we hit another established resistance level. If that does happen, I expect for these small biotechs that already have had good starts to the year to post further gains.